Adaptimmune Therapeutics PLC Quarterly Common Stock, Shares, Issued from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Adaptimmune Therapeutics PLC quarterly Common Stock, Shares, Issued history and growth rate from Q2 2014 to Q3 2024.
  • Adaptimmune Therapeutics PLC Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 1.53B shares, a 12.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.53B +173M +12.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 1.53B +182M +13.5% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 1.53B +539M +54.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.36B +376M +38.1% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 1.36B +379M +38.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 1.35B +375M +38.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 994M +52.8M +5.62% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 987M +49.6M +5.29% Dec 31, 2022 10-K 2024-03-06
Q3 2022 983M +45.7M +4.87% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 977M +40.5M +4.33% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 941M +8.05M +0.86% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 938M +8.79M +0.95% Dec 31, 2021 10-K 2023-03-06
Q3 2021 937M +8.52M +0.92% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 936M +8.57M +0.92% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 933M +152M +19.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 929M +298M +47.2% Dec 31, 2020 10-K 2022-03-14
Q3 2020 929M +298M +47.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 928M +297M +47.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 781M +152M +24.2% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 631M +3.55M +0.57% Dec 31, 2019 10-K 2021-02-25
Q3 2019 631M +3.73M +0.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 631M +64.2M +11.3% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 628M +63.4M +11.2% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 627M +65.3M +11.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 627M +65.1M +11.6% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 566M +5.39M +0.96% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 565M +45.9M +8.84% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 562M +137M +32.3% Dec 31, 2017 10-K 2019-02-27
Q3 2017 562M +137M +32.4% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 561M +136M +32.1% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 519M +94.3M +22.2% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 425M +63.2K +0.02% Dec 31, 2016 10-K 2018-03-15
Q3 2016 425M Sep 30, 2016 10-Q 2016-11-10
Q2 2016 425M 0 0% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 425M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 425M Dec 31, 2015 10-K 2017-03-13
Q2 2015 425M +243M +134% Jun 30, 2015 10-K 2017-03-13
Q2 2014 181M Jun 30, 2014 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.